Literature DB >> 5768129

Catecholamine and 5-hydroxyindole metabolism in immunosympathectomized rats.

P M Ceasar, C R Ruthven, M Sandler.   

Abstract

1. The daily urinary excretion of normetadrenaline, metadrenaline, 4-hydroxy-3-methoxyphenylglycol, 4-hydroxy-3-methoxymandelic acid, dopamine, homovanillic acid, 5-hydroxytryptamine and 5-hydroxyindolylacetic acid has been estimated in the urine of immunosympathectomized and control rats.2. A method is given which allows separate spectrophotometric determination of 4-hydroxy-3-methoxyphenylglycol and 4-hydroxy-3-methoxymandelic acid in the same sample of rat urine. Metadrenaline and normetadrenaline were estimated by a modification of the method of Anton & Sayre (1966).3. Approximately 17% of the 4-hydroxy-3-methoxymandelic acid in rat urine is excreted in the free state, over 60% as a glucuronide conjugate and the remainder as a sulphate conjugate.4. Urinary excretion of 4-hydroxy-3-methoxyphenylglycol was approximately halved in immunosympathectomized rats (P<0.001). 4-Hydroxy-3-methoxymandelic acid output was significantly increased in treated animals (P<0.05) when expressed in terms of body weight. No significant difference was detected for any of the other compounds investigated.5. The results are discussed in the light of previous knowledge of the effect of immunosympathectomy on catecholamine metabolism.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5768129      PMCID: PMC1703554          DOI: 10.1111/j.1476-5381.1969.tb08304.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  The estimation of 4-hydroxy-3-methoxymandelic acid in urine.

Authors:  M SANDLER; C R RUTHVEN
Journal:  Biochem J       Date:  1961-07       Impact factor: 3.857

2.  Studies on the formation of 3-methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine and epinephrine.

Authors:  M D ARMSTRONG; A McMILLAN
Journal:  Pharmacol Rev       Date:  1959-06       Impact factor: 25.468

3.  3-Methoxy-4-hydroxy-D-mandelic acid, a urinary metabolite of norepinephrine.

Authors:  M D ARMSTRONG; A McMILLAN; K N SHAW
Journal:  Biochim Biophys Acta       Date:  1957-08

4.  Factors affecting the enzymatic formation of O-methylated dihydroxy derivatives.

Authors:  J K Inscoe; J Daly; J Axelrod
Journal:  Biochem Pharmacol       Date:  1965-08       Impact factor: 5.858

5.  Catecholamines in organs of immunosympathectomized mice.

Authors:  M B Visscher; Y C Lee; T Azuma
Journal:  Proc Soc Exp Biol Med       Date:  1965 Aug-Sep

6.  The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals.

Authors:  L L Iversen; J Glowinski; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1966-02       Impact factor: 4.030

7.  Uptake and metabolism of d,1-norepinephrine-7H3 in tissues of immunosympathectomized mice and rats.

Authors:  F Sjöqvist; E Titus; I A Michaelson; P Taylor
Journal:  Life Sci       Date:  1965-06       Impact factor: 5.037

8.  Second symposium on catecholamines. Modification of sympathetic function. Immunosympathectomy.

Authors:  R Levi-Montalcini; P U Angeletti
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

9.  The effect of reserpine upon the synthesis of norepinephrine in the isolated rabbit heart.

Authors:  C O Rutledge; N Weiner
Journal:  J Pharmacol Exp Ther       Date:  1967-08       Impact factor: 4.030

10.  The quantitative determination of 3-methoxy-4-hydroxyphenylacetic acid (homovanillic acid) in urine.

Authors:  T L Sato
Journal:  J Lab Clin Med       Date:  1965-09
View more
  6 in total

1.  Threo-3,4-dihydroxyphenylserine, a poor source of noradrenaline in the rat.

Authors:  B L Goodwin; R D Johnson; B G Leask; C R Ruthven; M Sandler
Journal:  Experientia       Date:  1972-11-15

2.  The effect of experimental conditions on total urinary catecholamine excretion in the rat.

Authors:  J F Wing
Journal:  Br J Pharmacol       Date:  1972-11       Impact factor: 8.739

3.  Changes in plasma noradrenaline concentration as a measure of release rate.

Authors:  C R Benedict; M Fillenz; C Stanford
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

4.  Resistance of noradrenaline in blood vessels to depletion by 6-hydroxydopamine or immunosympathectomy.

Authors:  B A Berkowitz; S Spector; J H Tarver
Journal:  Br J Pharmacol       Date:  1972-01       Impact factor: 8.739

5.  Effect of selective destruction of central and peripheral catecholamine-containing neurones with 6-hydroxydopamine on catecholamine excretion in the rat.

Authors:  R Hoeldtke; M Rogawski; R J Wurtman
Journal:  Br J Pharmacol       Date:  1974-02       Impact factor: 8.739

6.  Conjugated HVA increase in rat urine after insulin-induced hypoglycemia: involvement of central dopaminergic structures but not of adrenal medulla.

Authors:  J M Cottet-Emard; L Peyrin
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.